Sequential Therapy Boosts Survival in Metastatic Pancreatic Cancer
(MedPage Today) -- For patients with metastatic pancreatic ductal adenocarcinoma (PDAC), sequential treatment with nab-paclitaxel (Abraxane) plus gemcitabine followed by modified oxaliplatin, leucovorin, and fluorouracil (mFOLFOX) led to improved...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Abraxane | Adenocarcinoma | Cancer | Cancer & Oncology | Eloxatin | Gastroenterology | Pancreas | Pancreatic Cancer